FDA reversals on UniQure, Moderna approvals worry investors

Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration.  The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from…

Read More

The top 10 analysts of 2025, as measured by TipRanks

Vcg | Visual China Group | Getty Images Wall Street analysts guide investors with their research and useful insights, but some consistently outperform others with strong, accurate calls. TipRanks, a platform that tracks and ranks analysts based on the accuracy and success of their recommendations, has released its list of analysts who stood out in…

Read More